|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.976
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.299
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.261
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.184
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.171
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.171
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.169
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.154
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.151
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.137
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.133
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.122
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.120
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.119
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.112
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.101
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.101
|
Human |
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.099
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.093
|
Human |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.093
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.092
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.091
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.088
|
Human |
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.086
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.083
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.081
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.080
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.075
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.075
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.073
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.069
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.068
|
Human |
|
|
habituation
|
GO:0046959 |
3 |
0.068
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.068
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.067
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.066
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.065
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.063
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.058
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.056
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.055
|
Human |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.055
|
Human |
|
|
protein alkylation
|
GO:0008213 |
81 |
0.055
|
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.052
|
Human |
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.052
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.051
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.049
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.049
|
|
|
|
regulation of cellular response to drug
|
GO:2001038 |
1 |
0.048
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.047
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.047
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.047
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.046
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.045
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.044
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.044
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.042
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.041
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.041
|
|
|
|
rna phosphodiester bond hydrolysis endonucleolytic
|
GO:0090502 |
10 |
0.040
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.039
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.039
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.039
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.038
|
Human |
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.038
|
Human |
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.037
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.037
|
|
|
|
regulation of translation ncrna mediated
|
GO:0045974 |
2 |
0.036
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.035
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.034
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.034
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.033
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.033
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.033
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.033
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.031
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.031
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.031
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.030
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.030
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.030
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.030
|
|
|
|
translation
|
GO:0006412 |
93 |
0.030
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.030
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.029
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.029
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.028
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.028
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.028
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.028
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
calcium mediated signaling using intracellular calcium source
|
GO:0035584 |
3 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.027
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.027
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.027
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.027
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.027
|
Human |
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.026
|
Human |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.026
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.026
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.025
|
Human |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.025
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.025
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.024
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.024
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.024
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.024
|
Mouse |
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.024
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.023
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.023
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.023
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.023
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.023
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.022
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.022
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.022
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.022
|
Human |
|
|
molting cycle
|
GO:0042303 |
90 |
0.022
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.022
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.022
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.021
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.021
|
Human |
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.021
|
Mouse |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.021
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.021
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.021
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.021
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.020
|
|
|
|
production of small rna involved in gene silencing by rna
|
GO:0070918 |
6 |
0.020
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.020
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.020
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.020
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
Human |
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.019
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.019
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.019
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.019
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.019
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.019
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.019
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.018
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.018
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.018
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.018
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.018
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.018
|
Human |
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.018
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.017
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.017
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.017
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.017
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.017
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.017
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.017
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.017
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.017
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.017
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.016
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.016
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.016
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.016
|
|
|
|
learning
|
GO:0007612 |
98 |
0.016
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.016
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.016
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.016
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.016
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.015
|
|
|
|
chromatin disassembly
|
GO:0031498 |
1 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.015
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.015
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.015
|
Human |
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.015
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.015
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.015
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.015
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.015
|
|
|
|
cellular response to drug
|
GO:0035690 |
15 |
0.015
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.014
|
|
|
|
mirna metabolic process
|
GO:0010586 |
10 |
0.014
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.014
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.014
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.014
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.014
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.014
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.014
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.014
|
Mouse |
|
|
hypermethylation of cpg island
|
GO:0044027 |
3 |
0.014
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.013
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.013
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.013
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.012
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.012
|
|
|
|
regulation of transcription from rna polymerase ii promoter by galactose
|
GO:0000431 |
1 |
0.012
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.012
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.012
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.012
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.012
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.012
|
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.012
|
Human |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.012
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.012
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.012
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.012
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.012
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.012
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.012
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.012
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
|
n terminal protein amino acid modification
|
GO:0031365 |
6 |
0.011
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.011
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.011
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.011
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.011
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.011
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.011
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.011
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.011
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.011
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.011
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.011
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.011
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.011
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.011
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.011
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.011
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.011
|
|
|
|
germ line stem cell maintenance
|
GO:0030718 |
6 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.011
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.011
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.011
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.011
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.011
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.011
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.011
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.010
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.010
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.010
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.010
|
|
|
|
negative regulation of translational initiation
|
GO:0045947 |
4 |
0.010
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.010
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.010
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.010
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.010
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.010
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
19 |
0.010
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.010
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.010
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.010
|
|